Stock Analysis·← Pickers

HYFT

MindWalk Holdings Corp.

MindWalk Holdings Corp. (HYFT) is currently in a downtrend, trading below both the 50-day and 200-day moving averages. RSI is at 47.7, with 0/3 trend checks passing.

Price
$1.49
2026-07-16
Trend score
0/3
Downtrend
RSI (14)
47.7
Neutral
Price above MA50Price above MA200MA50 above MA200
Change stock
Search another ticker to view its stock analysis page.
Chart View

HYFT with MA50 and MA200

3.202.662.111.561.0207/3110/2401/2204/1707/15
HYFT2025-07-312026-07-15
PriceMA50MA200
Technical Indicators

Key levels & signals

MA50
$1.52-1.83% vs price
MA200
$1.59-6.01% vs price
RSI (14)
47.7Neutral zone
MACD Signal
MixedMACD near signal line
Macro Support
Not identifiedNo repeated weekly support zone found
Support Quality
Volume data unavailable
Chart Summary
Trend summary for HYFT

MindWalk Holdings Corp. (HYFT) currently looks weaker on the chart and is not showing much trend strength. The latest available price is $1.49, and 0 of 3 core trend checks are currently passing. Price is trading below the 50-day moving average by 1.8% and below the 200-day moving average by 6.0%.

Momentum and stretch context

HYFT currently has an RSI reading of 47.7, which sits in a neutral range. That usually means momentum is not especially stretched in either direction, so traders may need to rely more on chart structure than on oscillator extremes alone.

What traders may watch next

For traders reviewing HYFT next, the main question is whether weakness is starting to stabilise or whether the chart still looks vulnerable to further downside. Some traders may watch for bounce attempts, but others will want to see stronger proof that the trend is improving before treating the stock as a cleaner setup.

Company profile

About MindWalk Holdings Corp.

MindWalk Holdings Corp. functions as an innovative bio-native artificial intelligence firm. Its core mission involves leveraging the synergy of AI, comprehensive multi-omics data, and sophisticated laboratory investigations to accelerate the identification and advancement of biological therapeutics. Utilizing its proprietary LensAI platform and HYFT technology, the company forges partnerships with pharmaceutical and biotechnology enterprises. These collaborations are designed to diminish the inherent risks associated with drug development and to unlock new possibilities for treatments. Founded in 1983, the company adopted its current name, MindWalk Holdings Corp., in September 2025, having previously been known as ImmunoPrecise Antibodies Ltd. Its corporate headquarters are located in Austin, Texas.

Sector
Healthcare
Industry
Biotechnology
CEO
Jennifer Lynne Bath
Employees
102
Market cap
$69.6M
Beta
0.83
52-week range
$0.99 – $3.25
Dividend
No
Exchange
NASDAQ
Country
US
IPO date
7 Jan 2002
ISIN
CA6026871054
CUSIP
602687105
Company profile data from Financial Modeling Prep. HYFT listed on NASDAQ.
Learn More

Learn the indicators behind this page

Explore More

More stock opportunities

FAQ

Common questions about HYFT

Is this page a buy or sell recommendation?

No. This page is designed to help you review chart structure, momentum and technical context more quickly, but it is not personal financial advice.

Why can a stock look bullish and overbought at the same time?

Strong trending stocks can still become stretched in the short term. That is why trend traders and dip buyers can read the same chart differently.

What should I do next after reading this page?

Open the full dashboard, review the chart in more detail, compare indicators, and decide whether the setup still makes sense within your own process.